[Follow-up of patients treated for an epithelial ovarian cancer, place of hormone replacement therapy and of contraception: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" dev

Date publication

février 2019

Journal

Gynecologie, obstetrique, fertilite & senologie

Auteurs

Membres identifiés du Cancéropôle Est :
Pr AKLADIOS Chérif

Tous les auteurs :
Sénéchal C, Akladios C, Bendifallah S, Ouldamer L, Lecuru F, Rousset-Jablonski C

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/30685388

Résumé

To define follow-up modalities after an epithelial ovarian, tubal or primitive peritoneal cancer. To define possibilities of hormone replacement therapy (HRT) and contraceptive use after treatment.

Mots clés

Cancer de l’ovaire, Contraception, Follow-up, Hormone replacement therapy, Ovarian cancer, Recurrence, Secondary cytoreductive surgery, Seconde chirurgie de la récidive, Surveillance, Traitement hormonal de la ménopause

Référence

Gynecol Obstet Fertil Senol. 2019 02;47(2):250-262